Biogened S.A. (WSE:BGD)

Poland flag Poland · Delayed Price · Currency is PLN
24.80
0.00 (0.00%)
At close: Apr 15, 2026
Market Cap60.92M -2.4%
Revenue (ttm)114.04M +2.8%
Net Income4.62M -20.6%
EPS1.88 -20.6%
Shares Out2.46M
PE Ratio13.18
Forward PEn/a
Dividend0.50 (2.02%)
Ex-Dividend DateSep 11, 2025
Volume5,643
Average Volume321
Open17.90
Previous Closen/a
Day's Range17.30 - 25.60
52-Week Range17.30 - 32.00
Beta0.20
RSI83.16
Earnings DateMay 15, 2026

About Biogened

Biogened S.A. produces and sells cosmetics and toiletries in Poland. The company offers dermo-cosmetics under the Dermedic brand; and thermal water. It also exports its products. The company was incorporated in 2007 and is headquartered in Lódz, Poland. [Read more]

Industry Pharmaceutical Preparations
Founded 2007
Employees 184
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BGD
Full Company Profile

Financial Performance

In 2025, Biogened's revenue was 114.04 million, an increase of 2.81% compared to the previous year's 110.93 million. Earnings were 4.62 million, a decrease of -20.59%.

Financial Statements